Drug details

Hetlioz LQ (tasimelteon oral suspension)

type of Melatonin Receptor Agonists

Hetlioz LQ (tasimelteon) is a melatonin receptor agonist used to treat nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) in pediatric patients 3 years to 15 years of age.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat, and
• pain or burning when you urinate

The following drugs are related to Hetlioz LQ, either as a replacement or used together:

• Ambien (zolpidem tartrate)
• Ambien CR (zolpidem tartrate)
• Dalmane (flurazepam)
• Hetlioz (tasimelteon capsules)
• Intermezzo (zolpidem tartrate)
• Restoril (temazepam)
• Sonata (zaleplon)